MINNEAPOLIS, March 28, 2016 /PRNewswire-USNewswire/ -- DaVita Clinical Research® (DCR®), a specialty contract research organization (CRO) with services spanning the full spectrum of drug and device development, has been awarded multiple Life Science Leader's 2016 CRO Leadership Awards.
Now in its fourth year, Life Science Leader's CRO Leadership Awards worked with Industry Standard Research (ISR) to determine award recipients, providing readers with accurate and reliable customer feedback to assist them in choosing a reputable partner for their clinical research needs. Winners are judged by their customers as either exceeding expectations or as top performers in five categories: capabilities, compatibility, expertise, quality and reliability.
"We strive to be the service provider of choice, and these awards indicate that we are meeting that goal and creating value for our customers," said Amy Young, vice president and general manager of DaVita Clinical Research.
DCR received an award in each of the five categories. The winners outperformed on 27 different metrics, as rated by decision-making executives at biopharmaceutical companies. Survey participants were recruited from pharmaceutical and biopharmaceutical companies of all sizes and were screened for decision-making influence related to working with CROs. Respondents only evaluate companies with which they have worked on an outsourced project within the past 18 months ensuring that survey responses are based on actual involvement with CROs and clear experiential data.
"Life Science Leader is proud to be working with ISR Reports to honor those CROs that have proven themselves to be the top performers in the five categories," said Ed Miseta, executive editor of Life Science Leader. "The CROs receiving an award this year are truly at the top of their class, and are deserving of the recognition they receive. Being a top performer in any of these categories shows a level of expertise and commitment to clinical trials and serving the needs of biopharmaceutical companies and their patients."
About DaVita Clinical Research (DCR)
DaVita Clinical Research (DCR), a wholly owned subsidiary of DaVita HealthCare Partners, Inc.,uses its extensive, applied database and real-world healthcare experience to assist pharmaceutical and medical device companies in the design, recruitment and completion of retrospective, prospective and pragmatic clinical trials. DCR's scientific and clinical expertise spans the lifecycle of product development with more than 175 client companies. DCR's Early Clinical Research unit (Phase I-IIa) and Late Phase Clinical Research (Phase IIb through post-marketing) network of physicians and investigative sites, Real World Healthcare Data,and Medical Communications are focused on providing world-class research in both complex/specialty populations and therapeutic areas, and especially in CKD and ESRD populations. To learn more about DCR, visit www.davitaclinicalresearch.com.
About DaVita HealthCare Partners
DaVita HealthCare Partners Inc., a Fortune 500® company, is the parent company of HealthCare Partners and DaVita Kidney Care. HealthCare Partners manages and operates medical groups and affiliated physician networks in Arizona, California, Nevada, New Mexico, Florida and Colorado in its pursuit to deliver excellent-quality health care in a dignified and compassionate manner. As of Dec.31, 2015 HealthCare Partners provided integrated care management for approximately 807,000 patients. DaVita Kidney Care is a leading provider of kidney care in the United States, delivering dialysis services to patients with chronic kidney failure and end stage renal disease. As of Dec. 31, 2015, DaVita Kidney Care operated or provided administrative services at 2,251 outpatient dialysis centers located in the United States serving approximately 180,000 patients. The company also operated 118 outpatient dialysis centers located in 10 countries outside the United States. For more information, please visit DaVitaHealthCarePartners.com.
SOURCE DaVita Clinical Research